Plasma Epstein–Barr Virus DNA for Screening

In this issue of the Journal, Chan et al. report on the monitoring of Epstein–Barr virus (EBV) DNA in plasma samples to screen a population that was at high risk for nasopharyngeal carcinoma. Although interest in monitoring circulating cell-free tumor DNA has surged, the application of this method…

http://ift.tt/2wKuLxL